GlaxoSmithKline and Prosensa reported this week that trials for a drug to treat Duchenne muscular dystrophy have failed to provide statistically significant improvement in muscle strength.
The trial assessed if patients were able to walk faster over a period of six minutes after taking a course of the new drug, drisapersen. However, the results showed no improvement when compared to a placebo.
The results are from the Phase III test, a late stage clinical trial. This major setback comes very late into the research and development. GlaxoSmithKline and Prosensa were leading the medical industry with a treatment for muscular dystrophy, however the news of their failure has caused Prosensa’s investors to start looking at alternative medical companies – Prosensa’s stock market price fell by 75% before trading opened.
Duchenne muscular dystrophy affects 1 in 3600 boys and causes muscle degeneration and eventually death. It is caused by a gene mutation and currently there is no effective treatment or cure and the condition results in paralysis, Children with the condition have a life expectancy of 25 years.
GSK suffered another set-back earlier this month after its drug to combat melanoma also failed to produce any meaningful results.
GlaxoSmithKline’s Carlo Russo said “We appreciate that these results will be disappointing for boys with DMD and their families”.
Hans Schikan, CEO for Prosensa said “While we are disappointed that this study did not meet its primary endpoint, we remain committed to the overall programme and will continue to work closely with GSK”.
Research is continuing in this area and hopefully future trials will be more successful.
The trials will be applying gene therapy and assessing its effectiveness as repairing damage following heart failure. read more
A small breakthrough in hearing science has been made. The journal Nature Medicine has published a paper detailing how congenital deafness can be prevented by treatment early in development to correct gene expression. Hearing impairment is the most common sensory … read more
Information about the various types of lasers and what their uses are in the medical field. Laser technology has only been used for a little more than fifty years. In another fifty years, we can only anticipate more evolution in the field of medicine. read more
In 2009 (or thereabouts) my son caught Hand, Foot and Mouth Disease. I was horrified, as I thought that it was a deadly disease. It seems that it is only really deadly for cattle, who are killed and buried when they … read more
Modic changes refer to the 3 different types of change in the trabeculae. that were first identified and examined by Dr. Michael Modic in 1988. Dr. Modic is the Institute Chair at the Cleveland Clinic Neurological Institute. read more
The Catalan Institute of Nanotechnology in Bellaterra, Spain has developed a new way to create complicated nanoparticle shapes. The chemical process hollows out particles made from silver with cationic gold. Cationic gold has had some electrons removed and when it comes into contact … read more
It was not that long ago that the medical community finally declared that mobile phones do not cause brain cancers, or any other serious health problems. However, mobile devices have not been given the all-clear just yet. The latest hypothesis being tested is that wi-fi networks, particularly those in mobile devices such as lap-tops and mobile phones, may damage sperm. read more
Psychotherapy is a widely misunderstood profession. The media present a variety of images of therapy (e.g., people laying on couches talking to a mostly silent therapist). Some of these images are more consistent with the actual practice of therapy, and … read more
A recent study by Swedish researchers which was published in the Journal of Epidemiology and Community Health has shown that people who remain in a lower social class are more prone to high blood pressure and developing associated diseases such as … read more